214
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics

, , &
Pages 315-319 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

PD Davis is the salaried founder, CEO and owner of Quanta BioDesign, Ltd, the company that invented the dPEG® process technology, which also develops, manufactures and markets products based on this core-process technology. Many of the studies referenced in this editorial article use products purchased from Quanta BioDesign, Ltd, or from companies who distribute the same. However, there are no financial interests in the specific projects related to the studies referenced herein, nor are there any financial gains by referencing the aforesaid. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.